Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD229 ( clone 2A12D). We employs the Retrovirus (trc-Cy3-IL-4-EcoRI) vector components and the SynExpress system of the exons Inversion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD229
Clone
2A12D
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
trc
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Retrovirus
Transformation Accuracy
0.89
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.